BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30327309)

  • 1. Association of CD4
    Veldwijk MR; Seibold P; Botma A; Helmbold I; Sperk E; Giordano FA; Gürth N; Kirchner A; Behrens S; Wenz F; Chang-Claude J; Herskind C
    Clin Cancer Res; 2019 Jan; 25(2):562-572. PubMed ID: 30327309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial.
    Azria D; Riou O; Castan F; Nguyen TD; Peignaux K; Lemanski C; Lagrange JL; Kirova Y; Lartigau E; Belkacemi Y; Bourgier C; Rivera S; Noël G; Clippe S; Mornex F; Hennequin C; Kramar A; Gourgou S; Pèlegrin A; Fenoglietto P; Ozsahin EM
    EBioMedicine; 2015 Dec; 2(12):1965-73. PubMed ID: 26844275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis for prediction of radiotherapy late toxicity: lymphocyte subset sensitivity and potential effect of TP53 Arg72Pro polymorphism.
    Fuentes-Raspall MJ; Caragol I; Alonso C; Ramón y Cajal T; Fisas D; Seoane A; Carvajal N; Bonache S; Díez O; Gutiérrez-Enríquez S
    Apoptosis; 2015 Mar; 20(3):371-82. PubMed ID: 25398538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Review of Radiation-Induced Lymphocyte Apoptosis as a Predictor of Late Toxicity After Breast Radiotherapy.
    Fhoghlú MN; Barrett S
    J Med Imaging Radiat Sci; 2019 Jun; 50(2):337-344. PubMed ID: 31176443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing the rate of late toxicity by changing the score? A comparison of RTOG/EORTC and LENT/SOMA scores.
    Hoeller U; Tribius S; Kuhlmey A; Grader K; Fehlauer F; Alberti W
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):1013-8. PubMed ID: 12605981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4 and CD8 T-lymphocyte apoptosis can predict radiation-induced late toxicity: a prospective study in 399 patients.
    Ozsahin M; Crompton NE; Gourgou S; Kramar A; Li L; Shi Y; Sozzi WJ; Zouhair A; Mirimanoff RO; Azria D
    Clin Cancer Res; 2005 Oct; 11(20):7426-33. PubMed ID: 16243816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RILA blood biomarker as a predictor of radiation-induced sarcoma in a matched cohort study.
    Mirjolet C; Merlin JL; Truc G; Noël G; Thariat J; Domont J; Sargos P; Renard-Oldrini S; Ray-Coquard I; Liem X; Chevreau C; Lagrange JL; Mahé MA; Collin F; Bonnetain F; Bertaut A; Maingon P
    EBioMedicine; 2019 Mar; 41():420-426. PubMed ID: 30827931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors for late normal tissue complications following radiotherapy for breast cancer.
    Lilla C; Ambrosone CB; Kropp S; Helmbold I; Schmezer P; von Fournier D; Haase W; Sautter-Bihl ML; Wenz F; Chang-Claude J
    Breast Cancer Res Treat; 2007 Nov; 106(1):143-50. PubMed ID: 17221151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy.
    Johansen J; Bentzen SM; Overgaard J; Overgaard M
    Radiother Oncol; 1996 Aug; 40(2):101-9. PubMed ID: 8884963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation-induced lymphocyte apoptosis to predict radiation therapy late toxicity in prostate cancer patients.
    Schnarr K; Boreham D; Sathya J; Julian J; Dayes IS
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1424-30. PubMed ID: 19167839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between radiation-induced apoptosis of T lymphocytes and chronic toxicity in patients with prostate cancer treated by radiation therapy: a prospective study.
    Foro P; Algara M; Lozano J; Rodriguez N; Sanz X; Torres E; Carles J; Reig A; Membrive I; Quera J; Fernandez-Velilla E; Pera O; Lacruz M; Bellosillo B
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1057-63. PubMed ID: 24661659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy.
    Azria D; Ozsahin M; Kramar A; Peters S; Atencio DP; Crompton NE; Mornex F; Pèlegrin A; Dubois JB; Mirimanoff RO; Rosenstein BS
    Clin Cancer Res; 2008 Oct; 14(19):6284-8. PubMed ID: 18829510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial breast irradiation with interstitial 60CO brachytherapy results in frequent grade 3 or 4 toxicity. Evidence based on a 12-year follow-up of 70 patients.
    Póti Z; Nemeskéri C; Fekésházy A; Sáfrány G; Bajzik G; Nagy ZP; Bidlek M; Sinkovics I; Udvarhelyi N; Liszkay G; Repa I; Galuska L; Trón L; Mayer A; Esik O
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1022-33. PubMed ID: 15001241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid assay of intrinsic radiosensitivity based on apoptosis in human CD4 and CD8 T-lymphocytes.
    Ozsahin M; Ozsahin H; Shi Y; Larsson B; Würgler FE; Crompton NE
    Int J Radiat Oncol Biol Phys; 1997 May; 38(2):429-40. PubMed ID: 9226332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical correlations between late normal tissue endpoints after radiotherapy: implications for predictive assays of radiosensitivity.
    Bentzen SM; Overgaard M; Overgaard J
    Eur J Cancer; 1993; 29A(10):1373-6. PubMed ID: 8398261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of the ratio of CD4+ to CD8+ T-cells on radiation-induced apoptosis in human lymphocyte subpopulations.
    Wilkins RC; Kutzner BC; Truong M; McLean JR
    Int J Radiat Biol; 2002 Aug; 78(8):681-8. PubMed ID: 12194751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-Dependent ROC Curve Analysis for Assessing the Capability of Radiation-Induced CD8 T-Lymphocyte Apoptosis to Predict Late Toxicities after Adjuvant Radiotherapy of Breast Cancer Patients.
    Touraine C; Winter A; Castan F; Azria D; Gourgou S
    Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes.
    Giotopoulos G; Symonds RP; Foweraker K; Griffin M; Peat I; Osman A; Plumb M
    Br J Cancer; 2007 Mar; 96(6):1001-7. PubMed ID: 17325707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of ATM rs1801516 on late skin reactions of radiotherapy for breast cancer: Evidences from a cohort study and a trial sequential meta-analysis.
    Terrazzino S; Cargnin S; Deantonio L; Pisani C; Masini L; Canonico PL; Genazzani AA; Krengli M
    PLoS One; 2019; 14(11):e0225685. PubMed ID: 31756226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro cellular radiosensitivity in relationship to late normal tissue reactions in breast cancer patients: a multi-endpoint case-control study.
    Vandevoorde C; Depuydt J; Veldeman L; De Neve W; Sebastià N; Wieme G; Baert A; De Langhe S; Philippé J; Thierens H; Vral A
    Int J Radiat Biol; 2016 Dec; 92(12):823-836. PubMed ID: 27586010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.